2.0
15 July 2012
Anonymous employee
Current employee, more than 3 years
Singapore
Recommend
CEO approval
Business outlook
Pros
Lots of opportunities if you are willing to stretch yourself A mature pharma division Strong innovation pipeline should see the company outperform other pharma majors in the near future
Cons
Bureaucracy A 'very poor' HR organization Inconsistent approach to managing change across divisions